studi
cytokin
profil
clinic
healthi
cat
natur
infect
felin
coronaviru
fcov
cat
felin
infecti
periton
fip
specif
pathogenfre
spf
cat
investig
whole
blood
use
tradit
reversetranscriptas
polymeras
chain
reaction
rtpcr
assay
semiquantit
method
analysi
base
computeris
quantif
posit
band
low
interassay
coeffici
variat
record
demonstr
method
highli
repeat
compar
spf
cat
cytokin
product
upregul
sampl
fcovposit
nonsymptomat
cat
appear
case
fip
catteri
associ
increas
express
cytokin
particular
increas
product
ifng
suggest
cytokin
might
protect
infect
cat
diseas
hypothesi
also
support
low
level
ifng
record
blood
cat
fip
c
ytokin
play
central
role
regul
cell
differenti
prolifer
cellecel
commun
balkwil
burk
differ
express
associ
diseas
activ
immunomedi
inflammatori
disord
mosmann
sad
characteris
cytokin
profil
peripher
blood
cell
make
possibl
estim
peripher
immun
state
physiolog
patholog
condit
stordeur
et
al
studi
cytokin
profil
cat
felin
infecti
periton
fip
fatal
diseas
induc
felin
coronavirus
fcov
provid
controversi
result
goitsuka
et
al
gunnmoor
et
al
dean
et
al
kiss
et
al
inform
avail
cytokin
profil
nonsymptomat
natur
fcovinfect
cat
known
clinicopatholog
chang
consist
cytokineinduc
protect
immun
paltrinieri
et
al
giordano
et
al
major
studi
perform
tissu
homogen
purifi
isol
cell
popul
like
peripher
blood
mononuclear
cell
pbmc
leutenegg
et
al
kipar
et
al
howev
approach
provid
limit
inform
cell
interact
vivo
defin
cytokin
product
furthermor
author
demonstr
cell
separ
procedur
influenc
mrna
level
cytokin
isol
pbmc
densiti
gradient
separ
increas
express
mrna
tnfa
et
al
ifng
higher
whole
blood
compar
pbmc
individu
stordeur
et
al
use
whole
blood
thu
consid
altern
method
evalu
cytokin
profil
approach
reduc
time
cost
associ
cell
isol
purif
requir
minim
sampl
manipul
data
obtain
reflect
accur
vivo
event
whole
blood
cultur
extens
use
human
medicin
ham
et
al
allen
et
al
rare
veterinari
medicin
yanci
et
al
duvigneau
et
al
knowledg
studi
evalu
cytokin
express
directli
felin
whole
blood
aim
present
report
develop
reversetranscriptas
polymeras
chain
reaction
rtpcr
assay
evalu
cytokin
profil
whole
blood
valid
semiquantit
method
interpret
rtpcr
result
investig
cytokin
profil
whole
blood
clinic
healthi
cat
natur
infect
fcov
cat
fip
compar
healthi
nonfcov
infect
specif
pathogenfre
spf
cat
studi
perform
blood
sampl
collect
cat
group
follow
tabl
group
four
clinic
healthi
persian
cat
live
fcovendem
catteri
approxim
cat
catteri
manag
order
provid
physic
separ
cat
specif
problem
pregnanc
parturit
infecti
diseas
etc
asymptomat
cat
share
environ
sporad
case
fip
per
year
occur
catteri
past
year
suggest
catteri
might
consid
endem
infect
fcov
cat
live
environ
colonis
intestin
fcov
may
cyclic
addi
jarrett
cat
sampl
interv
rang
month
order
assess
possibl
relationship
cytokin
pattern
actual
fcov
statu
specif
five
sampl
collect
cat
four
sampl
collect
cat
b
sampl
c
sampl
interv
sampl
day
day
day
case
fip
occur
day
sampl
day
sampl
group
three
cat
affect
fip
one
came
main
coon
breed
catteri
other
two
domest
shorthair
live
multicat
household
case
fip
record
past
cat
show
clinic
sign
consist
fip
sampl
euthanasia
submit
necropsi
three
case
clinic
suspicion
fip
confirm
postmortem
examin
includ
necropsi
histolog
immunohistochemistri
fcovantigen
perform
alreadi
describ
paltrinieri
et
al
group
three
spf
cat
perman
kept
anim
facil
vetsuiss
faculti
univers
zurich
time
sampl
cat
clinic
healthi
show
haematolog
biochem
abnorm
sampl
cytokin
pattern
whole
blood
investig
fcov
statu
cat
assess
antifcov
serolog
rtpcr
detect
faecal
shed
fcov
faecal
sampl
collect
cat
frozen
c
analysi
blood
collect
jugular
vein
put
edtaco
tube
complet
blood
cell
count
differenti
leukocyt
count
perform
anticoagul
blood
use
autom
cell
counter
hemat
seac
microscop
examin
may
grunwald
giemsa
stain
smear
respect
blood
centrifug
obtain
plasma
serolog
sampl
use
rna
extract
refriger
process
h
sampl
base
haematolog
result
use
volum
whole
blood
contain
total
amount
white
blood
cell
rna
extract
rna
extract
use
commerci
avail
kit
qiaamp
rna
blood
mini
kit
qiagen
milan
itali
accord
manufactur
instruct
avoid
contamin
genom
dna
gdna
dnase
treatment
perform
oncolumn
rnasefre
dnase
qiagen
prior
cdna
synthesi
ml
rna
sampl
subject
pcr
analysi
dehydrogenas
gapdh
sampl
demonstr
pcr
product
gapdh
consid
genom
contamin
subject
second
dnase
treatment
dnafre
ambion
cambridgeshir
unit
kingdom
recheck
dna
contamin
sampl
neg
gdna
second
dnase
treatment
synthesi
firststrand
cdna
templat
oligodt
ngml
carri
commerci
kit
readytogo
youprim
firststrand
bead
amersham
bioscienc
piscataway
nj
usa
volum
ml
c
min
follow
inactiv
revers
transcriptas
c
min
sampl
store
c
signal
felin
gapdh
cdna
use
normalis
differ
rna
extract
variabl
rt
pcr
effici
allow
comparison
sampl
particular
serial
dilut
cdna
sampl
perform
dilut
use
carri
pcr
gapdh
primer
gapdh
amplif
design
base
publish
sequenc
genbank
access
number
tabl
reaction
mix
prepar
volum
ml
contain
ml
cdna
buffer
mm
mgcl
mm
dntp
mm
primer
u
taq
polymeras
eppendorf
nucleasefre
water
neg
control
without
cdna
incorpor
set
pcr
reaction
pcr
reaction
perform
eppendorf
mastercycl
pcr
protocol
consist
denatur
c
anneal
c
extens
c
cycl
final
extens
step
c
min
ten
microlitr
reaction
product
visualis
agaros
gel
contain
ethidium
bromid
imag
gel
digit
photograph
ultraviolet
transillumin
gel
imag
subject
quantis
band
intens
use
freedownload
dedic
softwar
quantiti
one
basic
softwar
biorad
hercul
ca
usa
mean
band
intens
calcul
background
subtract
sampl
identifi
dilut
show
compar
intens
coeffici
variat
within
run
less
use
perform
pcr
cytokin
thu
ensur
compar
amount
start
cdna
materi
use
minimis
possibl
differ
cytokin
level
due
methodolog
variabl
cytokin
primer
sequenc
use
felin
tnfa
ifng
design
other
tabl
optimis
pcr
protocol
detect
cytokin
cdna
denatur
c
anneal
variou
temperatur
number
cycl
tabl
extens
c
final
extens
step
c
min
pcr
product
identifi
use
bp
standard
marker
gene
ruler
bp
dna
ladder
plu
fermenta
uab
vilniu
lit
primer
pair
shown
produc
singl
pcr
product
predict
size
gel
imag
reaction
analys
describ
gapdh
mrna
analysi
frozen
faec
thaw
g
faecal
sampl
homogenis
ml
salin
solut
centrifug
rpm
min
supernat
remov
filter
use
pore
size
mm
millipor
billerica
usa
three
millilitr
filter
supernat
appli
centricon
column
amersham
bioscienc
order
concentr
viral
particl
final
volum
ml
viral
rna
extract
use
qiaamp
viral
rna
mini
kit
qiagen
reversetranscrib
use
readytogo
youprim
firststrand
bead
kit
amersham
bioscienc
fcov
specif
primer
pmol
ml
herrewegh
et
al
cdna
amplifi
pcr
use
reaction
mix
compos
ml
cdna
buffer
mm
mgcl
mm
dntp
u
taq
polymeras
eppendorf
mm
primer
primer
use
herrewegh
et
al
thermal
cycl
protocol
use
c
min
cycl
denatur
c
anneal
c
elong
c
final
elong
step
c
min
batch
test
neg
control
reaction
mix
without
cdna
posit
control
fcov
cdna
amplifi
vaccin
primucel
fip
pfizer
anim
health
includ
amplicon
run
agaros
gel
visualis
use
uv
transillumin
base
presenc
absenc
amplicon
cat
classifi
posit
neg
cat
includ
studi
includ
spf
cat
test
refer
veterinarian
fiv
felv
use
inclin
elisa
test
snap
combo
idexx
lab
westbrook
usa
neg
antifcov
serolog
perform
use
indirect
immunofluoresc
test
slide
produc
univers
zurich
coat
well
cell
half
infect
swine
transmiss
gastroenter
viru
tgev
serolog
crossreact
fcov
osterhau
et
al
serolog
perform
follow
serial
twofold
dilut
serum
sampl
prepar
twenti
microlitr
dilut
appli
well
incub
min
c
humid
chamber
slide
wash
three
time
pb
dri
ml
fitcconjug
rabbitanti
cat
immunoglobulin
nordic
immunolog
laboratori
tilburg
netherland
appli
well
incub
min
c
humid
chamber
slide
wash
dri
coverslip
pb
kaiser
glycerin
ratio
observ
fluoresc
microscop
dilut
show
clear
fluoresc
signal
one
half
cell
judg
posit
sampl
still
posit
dilut
serial
dilut
twofold
basi
appear
neg
result
valid
semiquantit
approach
analys
rtpcr
product
order
valid
semiquantit
method
compar
result
obtain
differ
test
session
analys
data
record
preliminari
test
shown
express
cat
examin
pcr
test
bp
standard
marker
includ
randomli
chosen
band
mass
ladder
band
correspond
bp
case
ideal
candid
use
imag
calibr
valu
express
percentag
mean
intens
record
bp
band
assum
possibl
variat
amount
intens
record
bp
like
depend
gel
process
imag
analysi
procedur
verifi
reliabl
approach
sampl
spf
cat
h
includ
test
session
sampl
collect
second
sampl
analys
twice
randomli
chosen
cdna
differ
sampl
simultan
run
addit
batch
test
reanalys
accord
mention
approach
result
repeat
test
cat
use
calcul
mean
standard
deviat
coeffici
variat
cv
sdmean
stockham
scott
valu
regard
cytokin
express
evalu
imag
analysi
result
express
tradit
qualit
approach
posit
neg
also
semiquantit
approach
describ
semiquantit
data
record
three
group
cat
compar
use
nonparametr
kruskalew
test
follow
bonferroni
test
test
use
compar
result
record
sampl
time
group
cat
b
result
record
sampl
time
group
cat
group
cytokin
level
cat
fcov
faecal
shed
compar
cat
neg
faec
use
mannewhitney
u
test
possibl
presenc
correl
result
serolog
haematolog
cytokin
express
investig
use
spearman
correl
test
health
statu
cat
catteri
haematolog
antibodi
titr
fcov
excret
cat
group
never
show
clinic
sign
haematolog
abnorm
attribut
fip
infecti
diseas
sampl
period
nevertheless
day
sampl
day
sampl
two
episod
fip
occur
catteri
live
specif
episod
lead
death
two
kitten
one
cat
respect
antibodi
titr
amount
faecal
excret
fcov
also
variabl
among
differ
cat
sampl
tabl
statist
signific
correl
antibodi
titr
haematolog
paramet
found
postmortem
examin
reveal
cat
e
affect
dri
form
fip
sever
neurolog
renal
lesion
cat
f
g
typic
abdomin
effus
form
haemogram
reveal
cat
fip
anaem
lymphocytosi
cat
e
lymphopenia
cat
f
g
antibodi
titr
cat
fip
respect
healthi
nonfcov
infect
spf
cat
show
clinic
sign
haematolog
chang
sampl
circul
antifcov
antibodi
fcov
faec
repeat
protocol
possibl
compar
result
obtain
differ
test
session
investig
normalis
result
imag
analysi
function
imag
calibr
batch
test
see
exampl
fig
result
comparison
report
tabl
larg
major
case
cv
lower
specif
four
sampl
cv
lower
four
sampl
cv
two
addit
case
cv
cat
c
sampl
cat
h
cv
higher
high
cv
latter
sampl
howev
mostli
result
one
sampl
batch
significantli
lower
four
contrari
provid
similar
result
cv
four
measur
cat
group
express
fig
fig
detect
major
sampl
ifng
fig
tnfa
especi
rare
detect
tabl
nevertheless
number
cat
express
differ
cytokin
vari
among
differ
sampl
specif
cat
express
tnfa
detect
mainli
sampl
cat
express
ifng
sampl
contrari
cat
express
found
sampl
among
cat
fip
cat
e
posit
cytokin
except
cat
f
express
cat
g
posit
spf
cat
express
except
cat
also
express
tnfa
semiquantit
analysi
rtpcr
result
show
signific
differ
among
level
cytokin
record
differ
cat
group
among
group
cat
fcov
fip
spf
contrari
statist
analysi
reveal
significantli
higher
level
ifng
group
sampl
compar
group
sampl
spf
fip
cat
p
tabl
cytokin
level
differ
cat
shed
coronavirus
compar
fcovneg
faec
data
shown
group
level
ifng
express
significantli
correl
percentag
lymphocyt
blood
use
mrna
extract
p
r
tabl
compar
rtpcr
isol
cell
popul
analysi
whole
blood
advantag
small
number
exvivo
manipul
fewer
effect
cytokin
express
pattern
thu
provid
precis
inform
peripher
immun
statu
infect
cat
report
standard
rtpcr
reproduc
rel
quantif
mrna
method
like
competit
rtpcr
hall
et
al
final
use
specif
softwar
calcul
band
intens
easi
frequent
use
method
semiquantit
analysi
digitalis
gel
imag
harley
et
al
yanci
et
al
duvigneau
et
al
reason
use
tradit
rtpcr
techniqu
studi
cytokin
profil
felin
whole
blood
quantifi
band
intens
imag
analysi
method
allow
us
obtain
repeat
reliabl
result
thu
indic
use
compar
result
differ
test
session
order
correctli
interpret
result
howev
import
standardis
methodolog
factor
time
blood
collect
rna
extract
report
cold
storag
whole
blood
poorli
affect
amount
rna
extract
even
though
might
activ
cell
popul
duvigneau
et
al
nevertheless
standardis
process
time
would
affect
sampl
similar
manner
amount
cell
use
rna
extract
must
done
count
white
blood
cell
whole
blood
use
appropri
amount
blood
rna
extract
amount
cdna
use
pcr
reaction
use
semiquantit
method
number
rna
copi
band
unknown
base
result
normalis
gapdh
amount
cdna
load
pcr
reaction
imag
calibr
includ
gel
rel
amount
cytokin
express
differ
sampl
differ
batch
test
differ
group
cat
compar
case
studi
use
describ
approach
examin
whole
blood
cytokin
profil
cat
symptomat
nonsymptomat
fcov
infect
healthi
nonfcov
infect
spf
cat
use
spf
cat
neg
control
might
appear
unusu
immun
system
cat
expos
stimuli
nonspecif
infecti
agent
environment
stress
differ
nonspf
cat
hand
data
avail
regard
felin
cytokin
record
spf
cat
rottman
et
al
kipar
et
al
moreov
control
group
compos
valu
express
percentag
mean
intens
intern
calibr
bp
ladder
batch
analysi
repeat
computeris
quantif
express
perform
examin
mean
standard
deviat
sd
coeffici
variat
cv
none
sampl
includ
batch
repeatedli
analys
column
refer
batch
therefor
includ
tabl
fcovneg
nonspf
cat
fcovneg
multicat
household
would
better
control
group
would
repres
frequent
situat
practic
low
proport
multicat
household
less
area
actual
consid
fcovneg
percentag
fcovinfect
anim
larg
major
catteri
close
pedersen
group
found
persist
recurr
shedder
fluctuat
antibodi
titr
alreadi
report
fcovendem
catteri
addi
jarrett
postmortem
find
cat
group
consist
fip
sampl
popul
thu
consid
good
sampl
studi
natur
occur
fcovehost
interact
one
case
tnfa
detect
blood
spf
cat
partial
agreement
previou
report
howev
tnfa
consist
express
perhap
due
isol
procedur
induc
cell
activ
rottman
et
al
leutenegg
et
al
cytokin
express
group
characteris
high
individu
variabl
respons
lack
signific
differ
spf
cat
variabl
alreadi
report
gunnmoor
et
al
foley
et
al
unlik
variabl
might
depend
age
report
kipar
et
al
cat
differ
age
present
group
differ
breed
cat
belong
differ
group
given
breedassoci
variabl
cytokin
express
cat
demonstr
type
amount
cytokin
express
nonsymptomat
fcovinfect
cat
relat
faecal
shed
antibodi
titr
prior
appear
fip
catteri
percentag
clinic
healthi
fcovposit
cat
express
cytokin
median
level
ifng
significantli
increas
agreement
increas
certain
lymphocyt
subset
acut
phase
protein
paltrinieri
et
al
giordano
et
al
might
depend
express
cytokin
cat
remain
healthi
cat
catteri
develop
fip
posit
correl
ifng
express
lymphocyt
percentag
might
depend
fact
nonsymptomat
fcovinfect
cat
high
number
lymphocyt
paltrinieri
et
al
produc
high
level
ifng
caruso
et
al
find
suggest
intens
cytokin
product
peripher
blood
cell
specif
increas
express
ifng
might
protect
fcovinfect
cat
fip
kiss
et
al
ultim
fip
occur
low
pathogen
fcov
strain
mutat
acquir
abil
replic
within
macrophag
probabl
mutat
depend
rate
replic
enter
fcov
vennema
et
al
thu
possibl
viral
replic
lower
cat
mount
effici
immun
exampl
rtpcr
product
b
ifng
c
record
fcovexpos
cat
cytokin
express
pattern
record
cat
fip
consist
probabl
relat
differ
clinic
present
cytokin
pattern
consist
activ
innat
tnfa
cellmedi
immun
found
cat
e
dri
form
contrast
cytokin
profil
cat
f
g
wet
form
quit
silent
cat
express
low
level
cat
f
also
express
decreas
cytokin
express
alreadi
report
blood
experiment
infect
gunnmoor
et
al
contrast
record
tissu
dean
et
al
foley
et
al
ascit
high
level
record
goitsuka
et
al
interestingli
cat
fip
low
absent
ifng
express
also
ifng
found
upregul
within
lesion
foley
et
al
berg
et
al
downregul
blood
cat
fip
kiss
et
al
cytokin
profil
blood
therefor
seem
differ
tissu
cat
fip
moreov
low
level
ifng
record
cat
fip
compar
high
level
record
fcovposit
clinic
healthi
cat
support
hypothesi
rais
kiss
et
al
key
role
molecul
predispos
protect
fip
conclus
rtpcr
analysi
cytokin
pattern
whole
blood
use
evalu
immun
statu
cat
semiquantit
approach
base
analysi
digitalis
gel
imag
provid
repeat
result
analysi
whole
blood
consid
highli
repres
vivo
situat
result
support
hypothesi
upregul
cytokin
blood
cell
might
protect
fcovinfect
cat
fip
downregul
cytokin
especi
ifng
associ
fip
result
must
verifi
larger
well
control
studi
investig
role
cytokin
fcovehost
interact
possibl
use
cytokin
profil
identifi
cat
suscept
resist
fip
